2.43%XLF 15.10 
10.30%QQQQ 31.32 0.63%
Digg
Del.icio.us
Newsvine 
Facebook
Stumbleupon
REDWOOD CITY, Calif. - PDL BioPharma Inc. said director and interim Chief Executive L. Patrick Gage resigned due to differences among the board about prioritizing company goals.
| PDLI | 8.1 |  0.2 |
The biotechnology company previously announced that it is looking to separate its biotechnology assets into a separate publicly traded company; keep the rights to antibody humanization royalty revenue from current and future licensed products and distribute the income to stockholders; and continue to explore options to sell or securitize all or part of its antibody humanization royalties.
PDL said late Thursday that its three remaining board members will form a new Office of the Chair of the Board. The company also said board member Karen A. Dawes resigned for personal reasons.
Contemporary literature is a "literature of despair," this year's Nobel Prize winner for literature Jean-Marie Gustave Le Clezio s...
Jamie Lynn Spears -who delivered her first baby on June 19th at age 17- is not p...
In last week's report, I held out the prospect that the US government rescue package might result in a change in sentiment in financial mark...
|
Professional Website Design For Corporate - Get a Free Quote Today
Partners   
|
© 2008 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives
EMAIL
PRINT
RSS
SHARE
